↑  Read the latest from the desks  ·  fresh intelligence, published daily✦Quiet reading✦No ads, ever

✦Corporate brand & media services✦Made in Virginia Beach since 1997✦

Cencora: New ship (no warning signs)New ship

Cencora $COR

Grew revenue 9.3% in FY2025 to $321.3 billion, operating margin 0.8% against a 1.4% median for drugs, proprietaries & druggists' sundries, equity 2.0% of assets, and dividend per share up 17 years running.

Last filing8-K · Item 7.01 Regulation FD Disclosure, 4 Nov 2026

Next year, 80%$320.2B–$364.7B
Growth, on the year9.3%
Operating margin0.8%
Equity of assets2.0%
Credibility50%
Track record12 of 15
Your call, sealedNext year’s revenue, your range. Sealed now, graded when the annual report lands.
Edgarette’s full reading · exposure, experience, soundness, credibility, range

🫧 Edgar looked up CENCORA, INC. ($COR). Last filing: 8-K (7.01 Regulation FD Disclosure), 2026-11-04. 22 event filings (8-K) in the past twelve months.

🔖 Exposure: revenue $321.3B (FY2025), total debt $7.7B. Experience: revenue up 9.3% on the year, up 10.7% a year over 4 years; operating margin 0.8%, up from 0.7%. Soundness: equity 2.0% of assets, return on equity 104.0%, payout 27.9% of profit, dividend per share up 17 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $320.2B and $364.7B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $302.4B to $384.2B. A statistical range, not company guidance. Against peers (30 filers, $50M+ revenue, its industry group): operating margin 0.8% against a 1.4% median; growth 9.3% against 0.9%.

Read from its own SEC filings · nothing written, nothing inferred

CENCORA, INC. against its own record and its peers
Operating marginPeer median 1.4%0.8%Revenue, on the yearPeer median 0.9%9.3%Equity of assetsPeer median 29.9%2.0%Return on equityPeer median -4.7%104.0%Payout of profitPeer median 29.9%27.9%Gold tick: the median of 10–28 peers with $50M+ revenue in wholesale-drugs, proprietaries & druggists' sundries
Handed back now, or kept to compound · of each dollar of profit
27.9% paid out72.1% keptHanded back per share$2.2up 17 years runningGrowth its own profit can fund75.0%managed 9.3% last year

Gold paid out, navy kept. Kept share × return on equity = the growth it can fund itself. Facts from the filings, not a recommendation.

Speed and cash · fiscal 2025

Cash Compass⚡ Fast, cash not yet · growing fast, but little cash arriving so far
Inside viewTurns 1.2% of revenue into operating cash; revenue growing 10.4% a year over three years; pays and raised its dividend.
Outside viewAmong $10B+ companies: 7th percentile for cash, 78th for growth. cash growth

Both views must agree for a label · a description, not advice.

Cash flow (op · inv · fin · free)$3.9B · −$5.0B · $2.2B · $3.2B
Investment book (cash · short · long)$4.4B · — · — · current ratio 0.90
Revenue swing · equity of assets1.2% · 2.4%

Cencora is growing faster than its size class, with steadier revenue. Its own audited SEC figures.

The figures, as filed

Fiscal year end2025-09-30
Revenue$321.3B
Revenue, on the year9.3%
Revenue, a year over the record10.7%
Operating margin0.8%
Operating margin, prior year0.7%
Net margin0.5%
Research and developmentnot filed separately
Total debt$7.7B
Equity of assets2.0%
Return on equity104.0%
Payout of profit27.9%
Dividend per share$2.2 · up 17 years running
Earnings per share$8.02
Book value per share$7.72
Revenue per share$1646.05
Shares outstanding195,214,000
Audited years read5

Peers: the median of 30 filers with $50M+ revenue in wholesale-drugs, proprietaries & druggists' sundries.

Classic signals · fiscal 2025Altman Z″ 0.05 distress zone 1968Piotroski F 6 of 9 solid 2000Beneish M -2.54 below the −1.78 line 1999Sloan accruals -3.2% earnings backed by cash 1996DuPont ROE 145.6% = margin 0.5% × turns 4.47 × leverage 66.71

What a terminal subscription used to buy, a filing and arithmetic now give anyone. Published method, from the same filings. Display only: nothing here moves the range or its receipt. Why? →

Health HarborCencora sails as New shipno warning signs

Health watch · 12 monthsDirector or officer change ×6

Versus peersoperating margin 0.8% vs a 1.4% median · revenue growth 9.3% vs 0.9% · cash beats 7% of its size class · growth beats 78% 30 wholesale-drugs, proprietaries & druggists' sundries filers

Trend · last year to this▲operating margin 0.7% → 0.8% · ▲revenue $294.0B → $321.3B · 5-year revenue: $214.0B · $238.6B · $262.2B · $294.0B · $321.3B

See all 31 wholesale-drugs, proprietaries & druggists' sundries companies on POPS4 sorted from the newest ship to the boat at the dock
#CompanyConditionOperating marginRevenue growthSales
1New shipCentral Garden & Pet CompanyCENTNew ship8.0%−2.2%$3.1B
2New shipUniversalUVVNew ship5.8%−1.3%$2.9B
3New shipSyscoSYYNew ship3.7%3.9%$84.6B
4New shipChefs’ WarehouseCHEFNew ship3.5%9.4%$4.1B
5New shipUS Foods HoldingUSFDNew ship3.0%4.1%$39.4B
6New shipVestisVSTSNew ship2.4%−2.5%$2.7B
7New shipPerformance Food Group CompanyPFGCNew ship1.3%7.2%$67.8B
8New shipCencoraCOR · this companyNew ship0.8%9.3%$321.3B
9New shipUnited Natural Foods, Inc.UNFINew ship0.7%−2.0%$31.2B
10Sound shipDomino’s PizzaDPZSound ship19.3%5.0%$4.9B
11Sound shipWeyco Group, Inc.WEYSSound ship10.6%−4.9%$276.2M
12Sound shipPyxus InternationalPYYXSound ship6.7%−2.8%$2.4B
13Sound shipMcKESSONMCKSound ship1.5%12.4%$403.4B
14Sound shipChsCHSCPSound ship1.5%10.6%$39.2B
15Sound shipGlobal Partners LPGLPSound ship1.3%8.1%$18.6B
16Sound shipCardinal HealthCAHSound ship1.0%14.2%$254.2B
17Weathered boatRave Restaurant GroupRAVEWeathered boat26.9%7.2%$12.9M
18Weathered boatHF Foods GroupHFFGWeathered boat−2.7%2.2%$1.2B
19Weathered boatAshlandASHWeathered boat−42.5%−13.7%$1.8B
20Weathered boatEnerSyn GlobalESYNWeathered boat—−30.8%$0.9M
21Weathered boatEducational DevelopmentEDUCWeathered boat—−33.0%$22.9M
22Weathered boatAndersonsANDEWeathered boat—−2.2%$11.0B
23Old boatInnovative Food HoldingsIVFHOld boat4.3%2.1%$60.7M
24Old boatWorld KinectWKCOld boat−1.5%−12.5%$36.9B
25Old boatMgp IngredientsCASKOld boat−17.6%−23.8%$536.4M
26Old boatStark Focus GroupSKFGOld boat−204.3%69.9%$0.0M
27Rotting at the dockCosmos HealthCOSMRotting at the dock−25.6%19.9%$65.3M
28Rotting at the dockMarwynn HoldingsMWYNRotting at the dock−77.3%−61.2%$4.2M
29Rotting at the dockHydrofarm Holdings GroupHYFMRotting at the dock−206.3%−29.4%$134.3M
30Rotting at the dockCuentasCUENRotting at the dock−294.8%−71.2%$0.7M
31Rotting at the dockDataMeds AIMEDSRotting at the dock−401.7%28.7%$23.3M

From each company’s own POPS4 card. Green beats the industry median above, red trails it. Not a rating and not investment advice.

Sailing speed follows growth: 10.4% a year crosses the harbor in 49 seconds.

🌊 Visit the Bay →

No warning signs on the measures below.

Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an operating loss; negative free cash flow outside regulated utilities; an 80% revenue range of ±25% or wider. A picture of the signs, not a rating and not investment advice.

Brand success factors · calendar 2025

The Trillion Score: 531

Exponential Success Score

Built on over $200 trillion of sworn revenue, 13 years of data, 770,002 figures. Sealed by Edgarette.

How The Trillion Score works. We read eight measures of success from Cencora's own SEC filings and test each one against the public companies in its field, here wholesale drugs, proprietaries & druggists' sundries. The longer and fuller the record, the more weight those results carry. A model built on past filings then turns them into the odds of thriving, which means outgrowing the field for three years without a severe decline. A score of 500 is about average, and every 100 points doubles the odds. Every company is ranked on this same scale.

What it says here. At 531, Cencora's odds of thriving come to 42%, against about 37% for the typical filer. It meets 4 of 7 success points.

531The Trillion Score
42%modeled odds of thriving over three years
LowFall Risk
#6 of 19rank in its field
#886 of 2,824rank across all filers

What the score means

The higher the score, the more often companies went on to thrive. At this level, about 38 of every 100 did.

31%Under 45035%450 to 49938%500 to 549This company: 53144%550 to 59957%600 and up

Share of companies that beat their field for three years with no severe decline, tested on 2019 to 2022 filings.

Fall Risk: Low

Separate from the score, this asks what could go wrong: the odds of sales falling 30% or the filings stopping within three years. In the tests, about 7 of every 100 companies in the Low band did. That is the group's history, not a forecast for this company.

MoneyIt keeps about 1 cents of free cash from each sales dollar after paying for its plants and equipment. Debt after cash comes to about 2 cents for each dollar of yearly sales.low
SwingsEven in its worst years on record, sales still grew.5.6% a year
Filed eventsIn the last two years it told the SEC about 2 filings on layoffs, write-downs or cyber incidents, and 9 filings on leadership or auditor changes.11

The eight success points

PointWhat it meansPlace in field
SpeedSales grew faster than most of its field.95 of 100Met
SteadinessGrowth was strong for how much it swung, so it looks dependable.100 of 100Met
Price premiumIt keeps less of each sales dollar than the leaders in its field.20 of 100Not yet
Margin stays above the fieldIts margin has not held above the field for long.28 of 100Not yet
Moat half-lifeIts margin edge is fading fast, or it has none yet.33 of 100Not yet
Brand spend yieldBrand spending returns more gross profit than for most of its field.80 of 100Met
Learning curveCosts fell as a share of sales as it grew.78 of 100Met
Climb in the fieldNot filed.

Price premium -$34.8B is the extra gross profit over a field-median margin. Momentum $1.6B is gross profit times growth above the field's pace.

The actuarial view

CredibilityWith 8 years of filings, the record earns 61% of the weight. The rest stays at the middle of the field.0.61
Severe decline, class BAbout 26 of every 100 companies with this many points fell 30% or stopped reporting within three years.26.1%
Actual vs expectedSales are 51% higher than if it had simply kept pace with its field.1.51

Top of its field: #1 Hawkins · #2 MGP Ingredients · #3 Herbalife · #4 Pyxus International · #5 Weyco

Ranked by The Trillion Score. See the method and score your own brand. Tested on 2019 to 2022 filings. Odds, class and Fall Risk figures are the experience of similar filers, not a forecast for this company. A statistical description of past filings, not a rating or advice.

Recent filings
Measured, not prophesiedSuccess tools: score it, compare it, see its fieldFour questions. Scored against the SEC filings of the companies in your field.

Try InstagramSpriteHokaDisneyGatoradee.l.f.

Each benchmark is the median of SEC filers in your industry code, from their own audited filings, read on the filing boards. Reporting, not investment advice.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets and no trading recommendations. Figures from the SEC’s own data · every filing · this page as JSON · Open in Excel (CSV) · Ten-year table (CSV) ·

1 · Follow

Follow their filings

Or tap watch on any row above. You get the company’s live filing feed and Edgar’s card. Nothing to sign up for.

On Bluesky: follow Edgar & Edgarette.

2 · Price it

A new leader’s rebrand and launch

Priced live by the same engine as our estimator, from the catalogue at wholesale.

Price the printing · Open the full estimator

✦ Build the kit yourself
3 · Confirm

Check it with Jenny

Most buyers check what they found, or what their AI found, with one person before they commit. That person is the principal.

Jenny Huang Goodman MPA MSc MHSA, Principal

Book a time info@pops4.com
Independence. Every range, flag and score on these boards is identical for everyone. Clients of POPS4 or Hako Shikin receive no different numbers, no earlier access and no say in what is published. The service lines shown beside each board describe work we do; they never change the data. For reviewers: Method · Terms of use · Status
Free · unsponsored · source-linked

Clean data. No ads. Not now, not later.

Nine boards reading every SEC filing the business day after it lands, from the settled SEC daily index, ten editorial desks publishing daily, an open endpoint other AIs can query, and a 70,000-product house behind all of it. This is the public record end of it.

Every row is a filing.Straight from the company's own SEC document, linked. Nothing written, nothing inferred.
Nobody is watching you read.No ad trackers, no cookies from us. Our page counts are cookieless.
One email, one job.Watch a company and we hold that address for the alert alone. One tap ends it. Never shared, never passed on.
The house pays for this.Corporate event programs, corporate supplies and branded merchandise, since 1997. That is what funds the desks, under the house's own vendor standards.
Free to reuse with credit · CC BY 4.0 · how the boards are built
Data & Disclosure Notice: Edgar and Edgarette are automated software. Every figure on this page is calculated by software from public filings made by companies and funds with the U.S. Securities and Exchange Commission (EDGAR) and is published without individual human review. The accuracy and completeness of those filings are the responsibility of the filers; reports can contain errors and can be amended. Figures are shown as filed and as of each filing's date, and this page may be corrected or updated without notice. Ranges, expected returns, rankings, boats and other measures are statistical descriptions of past filings, not ratings, price forecasts, company guidance or recommendations; past results do not guarantee future results. This is general information published for all readers, not advice tailored to any person's portfolio, needs or circumstances, and nothing here is financial, investment, actuarial, legal, tax or other professional advice. Actuaries and other professionals who use these figures remain responsible for reviewing them for reasonableness and consistency against the original filings and for disclosing their reliance on them. No company, fund or reinsurer pays to be included or ranked. Provided as is, without warranty of any kind. Not affiliated with or endorsed by the SEC or by any company, fund or reinsurer named. All trademarks remain the property of their owners.